SonoScape Medical Corp. (SHE:300633)

China · Delayed Price · Currency is CNY

19.49

+0.89 (4.78%)

Jul 15, 2026, 11:54 AM CST

-32.37% (1Y)

Market Cap	7.90B -41.7%
Revenue (ttm)	2.36B +20.1%
Net Income	177.60M +253.2%
EPS	0.41 +255.5%
Shares Out	424.84M
PE Ratio	44.95
Forward PE	26.92
Dividend	0.18 (0.94%)
Ex-Dividend Date	Jun 5, 2026

Volume	6,152,443
Open	18.26
Previous Close	18.60
Day's Range	18.26 - 19.60
52-Week Range	17.20 - 37.73
Beta	-0.37
Analysts	Buy
Price Target	34.04 (+74.65%)
Earnings Date	Aug 22, 2026

About SonoScape Medical

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery soluti... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2002

Employees 3,133

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300633

Full Company Profile

Financial Performance

In 2025, SonoScape Medical's revenue was 2.31 billion, an increase of 14.65% compared to the previous year's 2.01 billion. Earnings were 197.28 million, an increase of 38.54%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 300633 stock is "Buy." The 12-month stock price target is ¥34.04, which is an increase of 74.65% from the latest price.

Price Target

¥34.04

(74.65% upside)

Analyst Consensus: Buy

Stock Forecasts